Reasons for Use of and Experiences with Homeopathic Treatment as an Adjunct to Usual Cancer Care: Results of a Small Qualitative StudyFunding This work was partly supported by Fonden af 1870. The fund had no role in the study design, or in the collection, analysis and interpretation of data; nor in the writing of the report, and in the decision to submit the article for publication.
15 May 2018
08 August 2018
21 September 2018 (online)
Background A significant proportion of patients with cancer consult with homeopaths. No former qualitative study has reported on experiences with homeopathy in this patient group. This study aimed to learn about the reasons for, and experiences with, treatment provided by homeopaths among Danish patients with cancer.
Methods A small qualitative semi-structured interview study was carried out to collect preliminary knowledge to learn about reasons for and experiences with treatment provided by homeopaths as an adjunct to usual care among patients with cancer. Thematic analysis was used for the development of themes.
Results Five patients, diagnosed with cancer, were interviewed. On the basis of qualitative interviews five themes emerged: concerns and hopes, obstacles and support, internal health locus of control, whole person approach, and improved well-being.
Conclusion The cancer patients in this study sought homeopathy to address their hopes and concerns and to help them face obstacles and find support. They were actively taking responsibility for their own health and valued the whole person approach used by their homeopaths. Participants reported improved well-being both at the physical and mental levels. The results provide a basis for further research to learn more from patients' experiences with this intervention. Such knowledge could potentially be helpful to improve healthcare practitioners' communication with patients, and thereby patients' overall care.
Keywordsqualitative - complementary and alternative medicine - homeopathy - cancer - thematic analysis
• This is the first qualitative study exploring cancer patients' experiences with homeopathy.
• Patients described concerns, hopes, obstacles and support in their treatment.
• Homeopathy was considered to be a whole person approach.
• Patients felt in control of their treatment and their well-being improved.
• This was a small study and more research is needed in this clinical field.
- 1 World Health Organization. Cancer: Data and Statistics Available at: http://www.euro.who.int/en/health-topics/noncommunicable-diseases/cancer . Accessed April 11, 2018
- 2 Møller B, Fekjaer H, Hakulinen T. , et al. Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer Prev 2002; 11 (Suppl. 01) S1-S96
- 3 Gatta G, Mallone S, van der Zwan JM, Trama A, Siesling S, Capocaccia R. ; EUROCARE Working Group. Cancer prevalence estimates in Europe at the beginning of 2000. Ann Oncol 2013; 24: 1660-1666
- 4 Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J. , et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49: 1374-1403
- 5 Luengo-Fernandez R, Leal J, Gray A, Sullivan R. Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol 2013; 14: 1165-1174
- 6 Frass M, Strassl RP, Friehs H, Müllner M, Kundi M, Kaye AD. Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review. Ochsner J 2012; 12: 45-56
- 7 Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther 2012; 11: 187-203
- 8 Christensen AI, Ekholm O, Davidsen M, Juel K. Sundhed og sygelighed i Danmark 2010 - og udviklingen siden 1987. Statens Institut for Folkesundhed, Syddansk Universitet; 2012
- 9 Pedersen CG, Christensen S, Jensen AB, Zachariae R. Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer. Eur J Cancer 2009; 45: 3172-3181
- 10 Nissen N, Lunde A, Pedersen CG, Johannessen H. The use of complementary and alternative medicine after the completion of hospital treatment for colorectal cancer: findings from a questionnaire study in Denmark. BMC Complement Altern Med 2014; 14: 388
- 11 Bishop F, Rea A, Lewith H. , et al. Complementary medicine use by men with prostate cancer: A systematic review of prevalence studies. Eur J Integr Med 2010; 2: 179-180
- 12 Klafke N, Eliott JA, Wittert GA, Olver IN. Prevalence and predictors of complementary and alternative medicine (CAM) use by men in Australian cancer outpatient services. Ann Oncol 2012; 23: 1571-1578
- 13 Kristoffersen AE, Norheim AJ, Fønnebø VM. Complementary and alternative medicine use among Norwegian cancer survivors: gender-specific prevalence and associations for use. Evid Based Complement Alternat Med 2013; 2013: 318781
- 14 Molassiotis A, Fernandez-Ortega P, Pud D. , et al. Complementary and alternative medicine use in colorectal cancer patients in seven European countries. Complement Ther Med 2005; 13: 251-257
- 15 Molassiotis A, Scott JA, Kearney N. , et al. Complementary and alternative medicine use in breast cancer patients in Europe. Support Care Cancer 2006; 14: 260-267
- 16 Molassiotis A, Panteli V, Patiraki E. , et al. Complementary and alternative medicine use in lung cancer patients in eight European countries. Complement Ther Clin Pract 2006; 12: 34-39
- 17 Fisher P. What is homeopathy? An introduction. Front Biosci (Elite Ed) 2012; 4: 1669-1682
- 18 Relton C, Cooper K, Viksveen P, Fibert P, Thomas K. Prevalence of homeopathy use by the general population worldwide: a systematic review. Homeopathy 2017; 106: 69-78
- 19 Becker-Witt C, Lüdtke R, Weisshuhn TE, Willich SN. Diagnoses and treatment in homeopathic medical practice. Forsch Komplementarmed Klass Naturheilkd 2004; 11: 98-103
- 20 Relton C, Chatfield K, Partington H, Foulkes L. Patients treated by homeopaths registered with the Society of Homeopaths: a pilot study. Homeopathy 2007; 96: 87-89
- 21 Lewith G. (2012) CAM use – the patients' perspective. In: CAMbrella. The Roadmap for European CAM Research. Bruxelles: Seventh Framework Programme; 2012
- 22 Molassiotis A, Fernadez-Ortega P, Pud D. , et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005; 16: 655-663
- 23 Guethlin C, Walach H, Naumann J, Bartsch HH, Rostock M. Characteristics of cancer patients using homeopathy compared with those in conventional care: a cross-sectional study. Ann Oncol 2010; 21: 1094-1099
- 24 Kassab S, Cummings M, Berkovitz S, van Haselen R, Fisher P. Homeopathic medicines for adverse effects of cancer treatments. Cochrane Database Syst Rev 2009; 2: CD004845
- 25 Rostock M, Naumann J, Guethlin C, Guenther L, Bartsch HH, Walach H. Classical homeopathy in the treatment of cancer patients--a prospective observational study of two independent cohorts. BMC Cancer 2011; 11: 19
- 26 Sencer SF, Zhou T, Freedman LS. , et al. Traumeel S in preventing and treating mucositis in young patients undergoing SCT: a report of the Children's Oncology Group. Bone Marrow Transplant 2012; 47: 1409-1414
- 27 Gaertner K, Müllner M, Friehs H. , et al. Additive homeopathy in cancer patients: Retrospective survival data from a homeopathic outpatient unit at the Medical University of Vienna. Complement Ther Med 2014; 22: 320-332
- 28 Frass M, Friehs H, Thallinger C. , et al. Influence of adjunctive classical homeopathy on global health status and subjective wellbeing in cancer patients - A pragmatic randomized controlled trial. Complement Ther Med 2015; 23: 309-317
- 29 Milazzo S, Russell N, Ernst E. Efficacy of homeopathic therapy in cancer treatment. Eur J Cancer 2006; 42: 282-289
- 30 Frenkel M. Is there a role for homeopathy in cancer care? Questions and challenges. Curr Oncol Rep 2015; 17: 43
- 31 Braun V, Clarke V. Successful Qualitative Research. London, United Kingdom: SAGE Publications; 2013
- 32 Chenail RJ. Interviewing the investigator: strategies for addressing instrumentation and researcher bias concerns in qualitative research. Qual Rep 2011; 16: 255-262
- 33 Noble H, Smith J. Issues of validity and reliability in qualitative research. Evid Based Nurs 2015; 18: 34-35
- 34 Rotter JB. Social Learning and Clinical Psychology. Englewood Cliffs, NJ: Prentice-Hall; 1954
- 35 Wallston BS, Wallston KA, Kaplan GD, Maides SA. Development and validation of the health locus of control (HLC) scale. J Consult Clin Psychol 1976; 44: 580-585
- 36 Hök J, Falkenberg T, Tishelman C. Lay perspectives on the use of biologically based therapies in the context of cancer: a qualitative study from Sweden. J Clin Pharm Ther 2011; 36: 367-375
- 37 Mulkins AL, Verhoef MJ. Supporting the transformative process: experiences of cancer patients receiving integrative care. Integr Cancer Ther 2004; 3: 230-237
- 38 Verhoef MJ, Rose MS, White M, Balneaves LG. Declining conventional cancer treatment and using complementary and alternative medicine: a problem or a challenge?. Curr Oncol 2008; 15 (02) (Suppl. 02) s101-s106
- 39 Verhoef MJ, White MA. Factors in making the decision to forgo conventional cancer treatment. Cancer Pract 2002; 10: 201-207
- 40 van Kleffens T, van Leeuwen E. Physicians' evaluations of patients' decisions to refuse oncological treatment. J Med Ethics 2005; 31: 131-136
- 41 Schützler L, Witt CM. Internal health locus of control in users of complementary and alternative medicine: a cross-sectional survey. BMC Complement Altern Med 2014; 14: 320
- 42 Rossi E, Vita A, Baccetti S, Di Stefano M, Voller F, Zanobini A. Complementary and alternative medicine for cancer patients: results of the EPAAC survey on integrative oncology centres in Europe. Support Care Cancer 2015; 23: 1795-1806
- 43 Salamonsen A. Doctor-patient communication and cancer patients' choice of alternative therapies as supplement or alternative to conventional care. Scand J Caring Sci 2013; 27: 70-76
- 44 Finfgeld-Connett D. Generalizability and transferability of meta-synthesis research findings. J Adv Nurs 2010; 66: 246-254